Websites, domains, hosts that links to xarelto.com
Our database shows, that the website xarelto.com is linked by a total of 6 websites.
Number of websites/domains displayed: 6
Results found: 6
Websites discovered:
AFib Stroke Risk & Treatment Info | Treat Your AFibhttp://pageoverview.com/website-report/myafibstory.com
Get the facts about the connection between atrial fibrillation and stroke risk, and how treatment may help you reduce your stroke risk.
- Expected expiration: July 10th in 2018
- Creation date: July 10th in 2014
- Renew date: June 9th in 2017
- Google Analytics: 6230610-16
XARELTO® (rivaroxaban) | Prescription Blood Thinnerhttp://pageoverview.com/website-report/xarelto-us.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
- Expected expiration: March 16th in 2019
- Creation date: March 16th in 2009
- Renew date: March 12th in 2017
- Google Analytics: 70816641-13
Janssen CarePath™ Patient Support Program | XARELTO® (rivaroxaban)http://pageoverview.com/website-report/xareltocarepath.com
Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.
- Expected expiration: March 17th in 2019
- Creation date: March 17th in 2011
- Renew date: March 13th in 2017
- Google Analytics: 70816641-13
XARELTO® (rivaroxaban) | Prescription Blood Thinnerhttp://pageoverview.com/website-report/drive4clots.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
- Expected expiration: January 15th in 2018
- Creation date: January 15th in 2015
- Renew date: December 15th in 2016
- Google Analytics: 70816641-13
XARELTO® (rivaroxaban) Information for Healthcare Professionals | XARELTO® (rivaroxaban) HCPhttp://pageoverview.com/website-report/xareltohcp.com
Discover XARELTO®, a Factor Xa inhibitor indicated to reduce stroke risk in patients with nonvalvular AF, to treat DVT & PE and for extended risk reduction, and for DVT prophylaxis after knee or hip replacement surgery.
- Expected expiration: September 5th in 2018
- Creation date: September 5th in 2008
- Renew date: September 1st in 2016
- Google Analytics: 6230610-8
Xarelto® - (rivaroxaban) - The Most Broadly Indicated NOAChttp://pageoverview.com/website-report/xarelto.com
Information about Xarelto (Rivaroxaban), stroke prevention in atrial fibrillation, treatment and prevention of VTE (DVT/PE) and Secondary Prevention after ACS
- Expected expiration: January 16th in 2019
- Creation date: January 16th in 2002
- Renew date: January 12th in 2017